Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Philips, Mari Anne ^a   Kingo, Külli ^a   Karelson, Maire ^a   Rätsep, Ranno ^a   Aunin, Eerik ^a   Reimann, Ene ^a   Reemann, Paula ^a   Porosaar, Orm ^b   Vikeså, Jonas ^c   Nielsen, Finn C ^c   Vasar, Eero ^a   Silm, Helgi ^a   Kõks, Sulev ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TALLINN CHILDREN S HOSPITAL   (Estonia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; COMPLEMENTARY DNA; GENOMIC DNA; GLUTAMINE; MELANOCYTE PROLIFERATING GENE 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; C12ORF10 PROTEIN, HUMAN; DNA; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; VITILIGO; ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; BLOOD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; MITOCHONDRION; REFERENCE VALUE; SKIN PIGMENTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEINS; REFERENCE VALUES; RNA, MESSENGER; SKIN PIGMENTATION; VITILIGO; YOUNG ADULT;

EID: 77950632221     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-56     Document Type: Article

References (25)

1. Zhang XJ, Chen JJ, Liu JB. The genetic concept of vitiligo. J Dermatol Sci 2005, 39:137-146. 10.1016/j.jdermsci.2005.06.004, 16140217.
2. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003, 16:208-214. 10.1034/j.1600-0749.2003.00032.x, 12753387.
3. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 2007, 20:271-278. 10.1111/j.1600-0749.2007.00384.x, 17630960.
4. Kingo K, Philips MA, Aunin E, Luuk H, Karelson M, Rätsep R, Silm H, Vasar E, Kõks S. MYG1, novel melanocyte related gene, has elevated expression in vitiligo. J Dermatol Sci 2006, 44:119-122. 10.1016/j.jdermsci.2006.08.001, 16996721.
5. Philips MA, Vikesaa J, Luuk H, Jonson L, Lilleväli K, Rehfeld JF, Vasar E, Kõks S, Nielsen FC. Characterization of MYG1 gene and protein: subcellular distribution and function. Biol Cell 2009, 101:361-373. 10.1042/BC20080086, 19014353.
6. Hawse JR, Hejtmancik JF, Huang Q, Sheets NL, Hosack DA, Lempicki R, Horwitz J, Kantorow M. Identification and functional clustering of global gene expression differences between human age-related cataract and clear lenses. Mol Vis 2003, 9:515-537. 2831407, 14551530.
7. Kõks S, Luuk H, Nelovkov A, Areda T, Vasar E. A screen for genes induced in the amygdaloid area during cat odor exposure. Genes Brain Behav 2004, 3:80-89. 10.1046/j.1601-183x.2003.00047.x, 15005716.
8. Sääf AM, Tengvall-Linder M, Chang HY, Adler AS, Wahlgren CF, Scheynius A, Nordenskjöld M, Bradley M. Global Expression Profiling in Atopic Eczema Reveals Reciprocal Expression of Inflammatory and Lipid Genes. PloS One 2008, 3:e4017. 10.1371/journal.pone.0004017, 2603322, 19107207.
9. Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das P. Autoimmune Diseases and Vitamin D Receptor Apa-I Polymorphism are Associated with Vitiligo in a Small Inbred Romanian Community. Acta Derm Venereol 2006, 86:209-214. 10.2340/00015555-0093, 16710576.
10. Dell'Anna ML, Urbanelli S, Mastrofrancesco A, Camera E, Iacovelli P, Leone G, Manini P, D'Ischia M, Picardo M. Alterations of mitochondria in peripheral blood mononulcear cells of vitiligo patients. Pigment Cell Res 2003, 16:553-559. 10.1034/j.1600-0749.2003.00087.x, 12950736.
11. Prignano F, Pescitelli L, Becatti M, Di Gennaro P, Fiorillo C, Taddei N, Lotti T. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Dermatol Sci 2009, 54:157-167. 10.1016/j.jdermsci.2009.02.004, 19282153.
12. The International HapMap Consortium The International HapMap Project. Nature 2003, 426:789-796. 10.1038/nature02168, 14685227, The International HapMap Consortium.
13. De La Vega FM, Gordon D, Su X, Scafe C, Isaac H, Gilbert DA, Spier EG. Power and sample size calculations for genetic case/control studies using gene-centric SNP maps: application to human chromosomes 6, 21, and 22 in three populations. Hum Hered 2005, 60:43-60. 10.1159/000087918, 16137993.
14. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
15. Kingo K, Aunin E, Karelson M, Rätsep R, Silm H, Vasar E, Kõks S. Expressional changes in the intracellular melanogenesis pathways and their possible role the pathogenesis of vitiligo. J Dermatol Sci 2008, 52:39-46. 10.1016/j.jdermsci.2008.03.013, 18514490.
16. Fitzsimons HL, Bland RJ, During MJ. Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 2002, 28:227-236. 10.1016/S1046-2023(02)00227-X, 12413421.
17. Rikitake Y, Moran E. DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol 1992, 12:2826-2836. 364477, 1534143.
18. Chan HM, La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 2001, 114:2363-2373.
19. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural Dimorphism in the Mitochondrial Targeting Sequence in the Human Manganese Superoxide Dismutase Gene A Predictive Evidence for Conformational Change to Influence Mitochondrial Transport and a Study of Allelic Association in Parkinson's Disease. Biochem Biophys Res Commun 1996, 226:561-565. 10.1006/bbrc.1996.1394, 8806673.
20. Audebert M, Charbonnier JB, Boiteux S, Radicella JP. Mitochondrial targeting of human 8-oxoguanine DNA glycosylase hOGG1 is impaired by a somatic mutation found in kidney cancer. DNA Repair 2002, 1:497-505. 10.1016/S1568-7864(02)00034-4, 12509224.
21. Wilder JA, Stone JA, Preston EG, Finn LE, Ratcliffe HL, Sudoyo H. Molecular population genetics of SLC4A1 and Southeast Asian Ovalocytosis. J Hum Genet 2009, 54:182-187. 10.1038/jhg.2009.12, 19229254.
22. Westerhof W, d'Ischia M. Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 2007, 20:345-359.
23. Dell'Anna ML, Picardo MA. Review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res 2006, 19:406-411. 10.1111/j.1600-0749.2006.00333.x, 16965269.
24. Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, Grammatico P, Picardo M. Increased sensitivity to peroxidative agents as possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997, 109:310-213. 10.1111/1523-1747.ep12335801, 9284096.
25. Jimbow K, Chen H, Park JS, Thomas PD. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Brit J Dermatol 2001, 144:55-65.